ES8504122A1 - Procedimiento para la obtencion de pirrolidinonas - Google Patents

Procedimiento para la obtencion de pirrolidinonas

Info

Publication number
ES8504122A1
ES8504122A1 ES534221A ES534221A ES8504122A1 ES 8504122 A1 ES8504122 A1 ES 8504122A1 ES 534221 A ES534221 A ES 534221A ES 534221 A ES534221 A ES 534221A ES 8504122 A1 ES8504122 A1 ES 8504122A1
Authority
ES
Spain
Prior art keywords
pyrrolidinones
potent
preparation
nervous system
central nervous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534221A
Other languages
English (en)
Other versions
ES534221A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES534221A0 publication Critical patent/ES534221A0/es
Publication of ES8504122A1 publication Critical patent/ES8504122A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/50—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C205/51—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE PIRROLIDINONAS DE FORMULA GENERAL (I), EN LA QUE R1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO; R2 REPRESENTA UN GRUPO ALQUILO O UN GRUPO FENILO; Y R3 REPRESENTA UN GRUPO TIENIL-2 O UN GRUPO FENILO.CONSISTE EN EFECTUAR UNA CICLISACION DE UN ESTER DE FORMULA GENERAL (II).DE APLICACION EN MEDICINA POR SU ACTIVIDAD SOBRE EL SISTEMA NERVIOSO CENTRAL, EN PARTICULAR COMO ANTICONVULSIVOS.
ES534221A 1983-07-12 1984-07-11 Procedimiento para la obtencion de pirrolidinonas Expired ES8504122A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8311636A FR2549053B1 (fr) 1983-07-12 1983-07-12 Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant

Publications (2)

Publication Number Publication Date
ES534221A0 ES534221A0 (es) 1985-04-16
ES8504122A1 true ES8504122A1 (es) 1985-04-16

Family

ID=9290775

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534221A Expired ES8504122A1 (es) 1983-07-12 1984-07-11 Procedimiento para la obtencion de pirrolidinonas

Country Status (23)

Country Link
US (1) US4604383A (es)
EP (1) EP0135406B1 (es)
JP (1) JPS6084265A (es)
KR (1) KR910003362B1 (es)
AR (1) AR240451A1 (es)
AT (1) ATE30150T1 (es)
AU (1) AU560725B2 (es)
CA (1) CA1249593A (es)
DD (2) DD227962A5 (es)
DE (1) DE3466686D1 (es)
DK (1) DK343784A (es)
ES (1) ES8504122A1 (es)
FI (1) FI77848C (es)
FR (1) FR2549053B1 (es)
GR (1) GR81502B (es)
HU (1) HU192564B (es)
IL (1) IL72324A (es)
NO (1) NO163617C (es)
NZ (1) NZ208865A (es)
PT (1) PT78874B (es)
SU (1) SU1391497A3 (es)
YU (2) YU121384A (es)
ZA (1) ZA845397B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
CA1336333C (en) * 1988-05-20 1995-07-18 Davide Della Bella Pyrrolidone-2 compounds and their use for central analgesic activity
GB9307431D0 (en) * 1993-04-08 1993-06-02 Oxford Asymmetry Ltd Improvements in or relating to chiral auxiliaries
CN106977415B (zh) * 2016-01-15 2021-03-26 广东东阳光药业有限公司 一种沙库必曲的中间体及其制备方法
WO2017148357A1 (zh) * 2016-02-29 2017-09-08 广东东阳光药业有限公司 一种沙库必曲的中间体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272842A (en) * 1965-06-25 1966-09-13 Lilly Co Eli Novel pyrrolinones
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
FR2436779A1 (fr) * 1978-09-22 1980-04-18 Pharmindustrie Derives de pyrrolidine-2 methanol utilisables comme medicaments

Also Published As

Publication number Publication date
YU121384A (en) 1986-10-31
YU81086A (en) 1986-10-31
JPS6084265A (ja) 1985-05-13
FR2549053B1 (fr) 1985-12-27
PT78874B (fr) 1986-06-02
KR850001165A (ko) 1985-03-16
IL72324A (en) 1987-10-30
HU192564B (en) 1987-06-29
FR2549053A1 (fr) 1985-01-18
FI77848B (fi) 1989-01-31
FI842795A (fi) 1985-01-13
NO163617B (no) 1990-03-19
CA1249593A (en) 1989-01-31
ES534221A0 (es) 1985-04-16
EP0135406B1 (fr) 1987-10-07
DE3466686D1 (en) 1987-11-12
DK343784A (da) 1985-01-13
US4604383A (en) 1986-08-05
NO163617C (no) 1990-06-27
IL72324A0 (en) 1984-11-30
KR910003362B1 (ko) 1991-05-28
NZ208865A (en) 1986-12-05
HUT34443A (en) 1985-03-28
DD229121A5 (de) 1985-10-30
DK343784D0 (da) 1984-07-12
EP0135406A1 (fr) 1985-03-27
ATE30150T1 (de) 1987-10-15
GR81502B (es) 1984-12-11
NO842821L (no) 1985-01-14
SU1391497A3 (ru) 1988-04-23
ZA845397B (en) 1985-02-27
AU3021684A (en) 1985-01-17
FI842795A0 (fi) 1984-07-11
DD227962A5 (de) 1985-10-02
AU560725B2 (en) 1987-04-16
AR240451A1 (es) 1990-04-30
FI77848C (fi) 1989-05-10
PT78874A (fr) 1984-08-01

Similar Documents

Publication Publication Date Title
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
HUP9802300A2 (hu) N-heteroaril-piridin-szulfonamid származékok, ezeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
ZA921804B (en) Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them.
HU9300898D0 (en) Non-aromatic heterocyclic compounds containing condensed nitrogenb
HUP9902471A2 (hu) Piperazin- és piperidinvegyületek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
DE3581566D1 (de) Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte.
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
ES8500900A1 (es) Procedimiento para preparar derivados de prolina disustituidos.
ES8504122A1 (es) Procedimiento para la obtencion de pirrolidinonas
ZA912618B (en) 3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them
DE3769563D1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
ATE18226T1 (de) Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
ES8401926A1 (es) Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.
ES8609319A1 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
ES2004467A6 (es) Procedimiento de preparacion de nuevos derivados de 1,4 dihidro-piridina
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
ES8401060A1 (es) Un procedimiento de preparacion de derivados de la 4-pipera-zinil-4-fenil-quinazolina.
ES8303425A1 (es) Procedimiento para la preparacion de nuevas cefalosporinas
ES8306481A1 (es) Procedimiento para la obtencion de sulfamidas anulares.
ES8502981A1 (es) Procedimiento de preparacion de derivados de piperacina.
ES8308565A1 (es) Procedimiento para la preparacion de compuestos de 1,4-benzodiazepina.
PT75251B (en) Process for the preparation of 6-<3,6-dihydro-1(2h)-pyridyl>-pyrimidine-3-oxides
GR3000773T3 (en) 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them
ES8307739A1 (es) "procedimiento para la preparacion de nuevos a1-pirrolin-tiolactimeteres".